Drug Overview

The CAPOX regimen is a widely used, powerful combination of two cancer-fighting medicines. It is a traditional chemotherapy treatment, primarily used to treat cancers of the digestive system, such as colon and stomach cancer.

The name “CAPOX” comes from the first letters of its two active drugs: CAPecitabine and OXaliplatin. By combining a pill you take at home with an infusion you receive at the clinic, this regimen provides a strong, two-pronged attack against cancer cells.

Generic names: Capecitabine and Oxaliplatin
US Brand names: Xeloda® (Capecitabine) and Eloxatin® (Oxaliplatin)
Drug Class: Combination Cytotoxic Chemotherapy (Antimetabolite + Platinum-based agent)
Route of Administration: Intravenous (IV) Infusion and Oral (Pills taken by mouth)
FDA Approval Status: Fully FDA Approved

What Is It and How Does It Work? (Mechanism of Action)

The CAPOX regimen works by combining two different chemotherapy drugs that attack cancer cells in completely different ways. Cancer cells multiply very quickly. To do this, they need to constantly copy their DNA (their internal instruction manual). CAPOX destroys this process.

Here is how each drug in the CAPOX regimen works at the molecular level:

Oxaliplatin (The “OX”): This drug is made with the heavy metal platinum. When it enters a cancer cell, it acts like chemical glue. It binds directly to the DNA strands and creates knots called “cross-links.” When the cancer cell tries to unzip its DNA to divide and multiply, it hits these knots and gets stuck. Unable to copy its DNA, the cell triggers a self-destruct sequence called apoptosis (programmed cell death).
Capecitabine (The “CAP”): This is a unique oral “prodrug.” This means the pill is not toxic when you swallow it. It travels through your blood and is specifically converted into a toxic drug called 5-fluorouracil (5-FU) directly inside the tumor. Once inside, 5-FU blocks an enzyme called thymidylate synthase. Without this enzyme, the cancer cell cannot make the basic building blocks it needs to repair the DNA damage caused by the oxaliplatin.

By using both drugs together, CAPOX traps the cancer cells: oxaliplatin damages the DNA, and capecitabine prevents the cell from fixing it.

FDA Approved Clinical Indications

Oncological Uses

Colorectal Cancer (Adjuvant): Used after surgery for Stage III colon cancer to destroy any microscopic cancer cells left behind and prevent the cancer from returning.
Metastatic Colorectal Cancer: Used as a primary treatment for bowel cancer that has spread to other parts of the body.
Gastric and Esophageal Cancers: Frequently used to treat cancers of the stomach and food pipe.

Non-oncological Uses

There are no FDA-approved non-oncological uses for the CAPOX regimen. It is strictly used to treat cancer.

Dosage and Administration Protocols

The CAPOX regimen is given in “cycles” that last 21 days (3 weeks). This schedule gives your healthy cells time to recover before the next round of treatment.

Drug	Standard Dose	Frequency in a 21-Day Cycle	Administration Notes
Oxaliplatin	130 mg/m² (based on body size)	Day 1 only	Given as an Intravenous (IV) infusion at the clinic, usually over 2 hours.
Capecitabine	1000 mg/m² (based on body size)	Days 1 through 14	Taken as a pill by mouth, twice a day (morning and evening). Days 15-21 are a rest period with no pills.

Dose Adjustments for Renal (Kidney) Insufficiency: Both drugs are cleared by the kidneys. If you have moderate kidney disease, your doctor will reduce the dose of capecitabine to 75% of the normal dose to prevent the drug from building up to dangerous levels.
Dose Adjustments for Hepatic (Liver) Insufficiency: Doctors will monitor your blood tests closely. If liver enzymes become too high, treatment may be paused or doses lowered until the liver recovers.

Clinical Efficacy and Research Results

Recent clinical data (from major studies like the IDEA collaboration, reviewed between 2020 and 2025) has shown that CAPOX is highly effective, and doctors have learned how to use it more safely.

Shorter Treatment Times: For patients with low-risk Stage III colon cancer, research proved that receiving just 3 months of CAPOX is just as effective as the traditional 6 months. This was a major breakthrough because it greatly reduced the risk of permanent nerve damage while keeping the 3-year disease-free survival rate high, at approximately 83%.
Metastatic Survival: When used for advanced, spreading colorectal cancer, CAPOX shrinks tumors in about half of all patients. When CAPOX is combined with modern Targeted Therapies (like bevacizumab), it can significantly extend a patient’s overall survival to well over two years, turning a fast-growing disease into a manageable chronic condition for many.

Safety Profile and Side Effects

Because CAPOX is a strong chemotherapy, it affects both cancer cells and healthy cells, causing specific side effects.

Black Box Warnings

Capecitabine & Warfarin: Capecitabine heavily interacts with the blood thinner warfarin (Coumadin), dangerously increasing the risk of fatal bleeding.
Oxaliplatin Allergies: Oxaliplatin can cause severe, life-threatening allergic reactions (anaphylaxis) during the IV infusion.

Common Side Effects (>10%)

Cold Sensitivity (Neuropathy): Oxaliplatin causes a very unique side effect where touching cold objects or drinking cold drinks causes painful tingling or an electric-shock feeling in the hands, feet, and throat.
Hand-Foot Syndrome: Caused by capecitabine, this makes the palms of the hands and soles of the feet become red, swollen, and start to peel.
Diarrhea and Nausea.
Fatigue: Feeling unusually tired.

Serious Adverse Events

Permanent Peripheral Neuropathy: If nerve damage from oxaliplatin gets too severe, the numbness and pain in the hands and feet can become permanent.
DPD Enzyme Deficiency Toxicity: A small number of patients genetically lack the DPD enzyme needed to process capecitabine. For these patients, the drug can build up and cause life-threatening diarrhea, mouth sores, and dangerously low white blood cell counts.
Severe Myelosuppression: A dangerous drop in white blood cells, increasing the risk of severe infections.

Management Strategies

For Cold Sensitivity: Wear gloves when opening the refrigerator, dress warmly in cold weather, and only drink room-temperature liquids for several days after your IV infusion.
For Hand-Foot Syndrome: Apply thick, urea-based moisturizing creams to your hands and feet multiple times a day. Avoid tight shoes and hot water.
For Diarrhea: Keep over-the-counter loperamide (Imodium) at home. Call your doctor immediately if you have more than 4 loose stools a day.

Research Areas

While CAPOX is a traditional chemotherapy, it plays a vital role in the latest Immunotherapy and Targeted Therapy research. Tumors in the colon and stomach often build a chemical “shield” to hide from the body’s immune system. Researchers have found that the cell damage caused by CAPOX helps break down this shield. Today, clinical trials are combining the CAPOX regimen with modern immunotherapy drugs (like pembrolizumab or nivolumab) to see if the chemotherapy can effectively “open the door” for the immunotherapy to completely wipe out the cancer.

Patient Management and Practical Recommendations

Pre-Treatment Tests to be Performed

DPD Enzyme Testing: Highly recommended (and required in some European regions) to ensure you do not have a genetic risk for severe capecitabine toxicity.
Comprehensive Metabolic Panel (CMP): To thoroughly check kidney and liver function.
Complete Blood Count (CBC): To establish baseline blood cell levels.

Precautions During Treatment

Pregnancy Warning: This regimen can cause severe birth defects. Men and women must use highly effective birth control during treatment and for several months after the last dose.
Infection Risk: Your immune system will be temporarily weak. Wash your hands frequently and avoid large crowds or sick people.

“Do’s and Don’ts” list

DO take your capecitabine pills within 30 minutes after finishing a meal (usually breakfast and dinner) with a large glass of room-temperature water.
DO check your temperature at home. Call your doctor immediately if you have a fever over 100.4°F (38°C).
DO tell your doctor if the tingling in your fingers makes it hard to button your shirt or pick up small objects. They can lower the dose to protect your nerves.
DON’T drink ice water, eat ice cream, or breathe in deeply in cold weather for the first 3 to 5 days after your oxaliplatin infusion.
DON’T crush or chew the capecitabine pills. They must be swallowed whole.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. Treatment protocols, dosages, and side effects vary by individual and by specific medical conditions. Patients should always consult with their primary oncologist, pharmacist, or a qualified healthcare professional regarding diagnosis, treatment options, and the management of medical conditions. Do not disregard professional medical advice or delay in seeking it because of something you have read in this material.